Yatharth Hospital Share Price Rises After Board Approves QIP
Yatharth Hospital & Trauma Care Services Ltd.'s share price rose over 3% after the company approved raising funds via qualified institutional placement. Equity shares of face value of Rs 10 will be issued in the QIP.
A special resolution was passed by the members of the company in an extraordinary general meeting held on Dec. 6. The Securities Issue Committee at its meeting had authorised the opening of the issue on Wednesday.
The board also approved the floor price of Rs 626.18 per equity share for the issue. The company will offer a discount of up to 5% on the floor price.
The objective of the QIP is the repayment or pre-payment, in full or in part, of certain outstanding borrowings of the company and subsidiaries.
According to the term sheet viewed by NDTV Profit, the company is set to issue Rs 700 crore. Some of the subsidiaries of the company include AKS Medical & Research Centre Pvt. and Pristine Infracon.
The QIP will also account for acquisition funding for two hospitals situated in Model Town, Delhi and Faridabad, Haryana. The purpose of the QIP will also account for purchase of medical equipment and general corporate purposes.
Yatharth Hospital Share Price

Yatharth Hospital's share price rose as much as 3.34% during the day to Rs 634.50 apiece on the NSE. It was trading 2.30% higher at Rs 638.15 apiece, compared to a 1.02% decline in the benchmark Nifty 50 as of 10:29 a.m.
The stock has risen 58.32% in the last 12 months and 62.62% on a year-to-date basis. Total traded volume so far in the day stood at 4.7 times its 30-day average. The relative strength index was at 48.44.
All six analysts tracking the company have a 'buy' rating on the stock, according to Bloomberg data. The 12-month analysts' consensus target price on the stock is Rs 795, implying an upside of 28.5%
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.